Estimated Burden of Community-Onset Respiratory Syncytial Virus-Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014-15
- PMID: 31868913
- PMCID: PMC7107566
- DOI: 10.1093/jpids/piz087
Estimated Burden of Community-Onset Respiratory Syncytial Virus-Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014-15
Abstract
Background: Respiratory syncytial virus (RSV) is a major cause of hospitalizations in young children. We estimated the burden of community-onset RSV-associated hospitalizations among US children aged <2 years by extrapolating rates of RSV-confirmed hospitalizations in 4 surveillance states and using probabilistic multipliers to adjust for ascertainment biases.
Methods: From October 2014 through April 2015, clinician-ordered RSV tests identified laboratory-confirmed RSV hospitalizations among children aged <2 years at 4 influenza hospitalization surveillance network sites. Surveillance populations were used to estimate age-specific rates of RSV-associated hospitalization, after adjusting for detection probabilities. We extrapolated these rates using US census data.
Results: We identified 1554 RSV-associated hospitalizations in children aged <2 years. Of these, 27% were admitted to an intensive care unit, 6% needed mechanical ventilation, and 5 died. Most cases (1047/1554; 67%) had no underlying condition. Adjusted age-specific RSV hospitalization rates per 100 000 population were 1970 (95% confidence interval [CI],1787 to 2177), 897 (95% CI, 761 to 1073), 531 (95% CI, 459 to 624), and 358 (95% CI, 317 to 405) for ages 0-2, 3-5, 6-11, and 12-23 months, respectively. Extrapolating to the US population, an estimated 49 509-59 867 community-onset RSV-associated hospitalizations among children aged <2 years occurred during the 2014-2015 season.
Conclusions: Our findings highlight the importance of RSV as a cause of hospitalization, especially among children aged <2 months. Our approach to estimating RSV-related hospitalizations could be used to provide a US baseline for assessing the impact of future interventions.
Keywords: RSV; children; disease burden.
Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society 2019.
Figures


Similar articles
-
Estimates of hospitalization attributable to influenza and RSV in the US during 1997-2009, by age and risk status.BMC Public Health. 2017 Mar 21;17(1):271. doi: 10.1186/s12889-017-4177-z. BMC Public Health. 2017. PMID: 28320361 Free PMC article.
-
Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008.Clin Infect Dis. 2012 May;54(10):1427-36. doi: 10.1093/cid/cis211. Epub 2012 Apr 10. Clin Infect Dis. 2012. PMID: 22495079 Free PMC article.
-
SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis.Am J Perinatol. 2020 Mar;37(4):421-429. doi: 10.1055/s-0039-1681014. Epub 2019 Apr 16. Am J Perinatol. 2020. PMID: 30991438
-
Acute Lower Respiratory Infections Associated With Respiratory Syncytial Virus in Children With Underlying Congenital Heart Disease: Systematic Review and Meta-analysis.J Infect Dis. 2020 Oct 7;222(Suppl 7):S613-S619. doi: 10.1093/infdis/jiz150. J Infect Dis. 2020. PMID: 31599958
-
Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review.BMC Infect Dis. 2024 Aug 20;24(1):844. doi: 10.1186/s12879-024-09758-3. BMC Infect Dis. 2024. PMID: 39164625 Free PMC article.
Cited by
-
Clinical and economic burden of respiratory syncytial virus in Spanish children: the BARI study.BMC Infect Dis. 2022 Sep 29;22(1):759. doi: 10.1186/s12879-022-07745-0. BMC Infect Dis. 2022. PMID: 36175846 Free PMC article.
-
Respiratory Syncytial Virus-Associated Respiratory Diseases in Children and Adults.Dtsch Arztebl Int. 2024 May 3;121(9):303-312. doi: 10.3238/arztebl.m2024.0060. Dtsch Arztebl Int. 2024. PMID: 38652840 Free PMC article. Review.
-
Pediatric Respiratory Hospitalizations in the Pre-COVID-19 Era: The Contribution of Viral Pathogens and Comorbidities to Clinical Outcomes, Valencia, Spain.Viruses. 2024 Sep 25;16(10):1519. doi: 10.3390/v16101519. Viruses. 2024. PMID: 39459854 Free PMC article.
-
Clinical Burden of Respiratory Syncytial Virus in Hospitalized Children Aged ≤5 Years (INSPIRE Study).J Infect Dis. 2022 Aug 26;226(3):386-395. doi: 10.1093/infdis/jiac137. J Infect Dis. 2022. PMID: 35417015 Free PMC article.
-
Systematic Literature Review of Respiratory Syncytial Virus Laboratory Testing Practices and Incidence in United States Infants and Children <5 Years of Age.J Infect Dis. 2022 Aug 15;226(Suppl 2):S213-S224. doi: 10.1093/infdis/jiac203. J Infect Dis. 2022. PMID: 35968874 Free PMC article.
References
-
- Hall CB, Weinberg GA, Blumkin AK, et al. . Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics 2013; 132:e341–8. - PubMed
-
- Izurieta HS, Thompson WW, Kramarz P, et al. . Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000. 342:232–9. - PubMed
-
- Stockman LJ, Curns AT, Anderson LJ, Fischer-Langley G Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997.– Pediatr Infect Dis J 2012; 31: 5–9. - PubMed